Theophylline (T) is known to produce cerebral vasoconstriction in both animals and humans. It is unclear whether these e f f e c t s vary regionally, especially in the developing brain. Using the tracer iodo- [14c] antipyrine and the indicator-fractionation technique described by Cavazutti and Duffy, we studied rCBF in awake newborn dogs ( 3 to 9 days old), treated with either saline (n=4) or T (n=3).
Catheters were placed in the right common carotid artery and the right external jugular vein while under halothane anesthesia. Following a 4 hour recovery period, either T, 45 mg/kg, or saline was administered by slow iV infusion. After an additional 1 hour equilibration period, the rCBF measurement was performed. pC02, measured just prior to rCBF determination, was 36 t 3 mm Hg (rnean f S.D.) in the saline group and 26 i 6 mm Hg in the T group. T levels in treated animals equaled 38 i 4 !Jg/ml. RCBF in the saline group ranged from 6 m1/100 gm/min insubcortical white matter to 75 mlllOOglmin in the oculomotor n. nucl. T treated dogs, when compared to saline treated dogs, had lower values in all 28 areas of the brain analyzed. Thalamic and midbra~n nuclei showed the greatest reductions (35-48%). At the other extreme, medullary and cerebellar structures showed little reduction (7-16%) with T. Though exceptions were noted, the degree of T associated reduction in rCBF generally paralleled reported newborn dog C02 -CBF sensitivity. 7-day old rats (15 g body weight) were injected subcutaneously with iodo-[14c] antipyrine ( 5 yCi). After a variable period, each pup was decapitated and arterial blood collected for scintillation counting. Brains were immediately removed and either prepared for isotopic counting or frozen for autoradiography. The brain: blood partition coefficient was determined (0.944 f .066 ml/g (mean f S.E. )). Both cerebral hemispheric blood flow (CHBF) and rCBF were calculated according to a formula derived from the Fick equation. CHBF equaled 66 f 4 m1/100 glmin (mean f S.E.), a value midway between reported I-day old rat CBF and adult rat CBF. Autoradiograms were of sufficient quality to permit microdensitometric readings of a minimum of 11 structures. rCBF ranged from 20 ml/ 100 g/min in subcortial white matter to 71 m1/100 g/min in the brain stem. Immature rat rCBF, as a proportion of adult rat rCBF, was greatest in brain stem.
Other 7 day old rats underwent right common carotid artery ligation and subsequent exposure to an 8% O2 environment. Right hemispheric flow was reduced to less than 5% of left hemispheric flow. This reduction was greatest in the distribution of the right middle cerebral artery. Vascular columns perpendicular to the pial surface, corresponding to columns seen metabolically and histopathologically, were not found. Thus, we have developed a relatively simple means of measuring rCBF in the immature rat and we have used it to study a model of cerebral hypoxia-ischemia. Although S-TA has been used i n t h e treatment of HMD, t h e optimal time of therapy i s n o t established. We compared t h e p h y s i o l og i c responses t o u l t r a e a r l y (UE) and l a t e (LT) treatment of S-TA therapy i n preterm baboons (76%of term). After C-sectionthey were intubated and v e n t i l a t e d . S-TA 100 mglkg was i n s t i l l e d a t 10' i n UE group and a t 2 h r s . i n LT group. A l l were t r e a t e d t o maintain normoxia. normocarbia, and normal pH r a n g e . S e q u e n t i a l d a t a a r e shown below. Improvement i n compliance (CL) was s i g n i f i c a n t l y Time (post s u r f . ) Pre-1 h r . Post-1 hr. Post-6 h r . Post-14 h r . IWr LT 1 4 . 5 i l . l 13.ri1.6 11.7+0.7 10.Tf0.5 (Table: X f S.D., *p<@.O5, **p<0.01, ***p<0.005) b e t t e r i n UE than LT group. Mean airway p r e s s u r e ( M A P ) dropped s i g n i f i c a n t l y i n UE group reaching 5.2k2.2 cmH20 a t 14 h r s . P-V curves of lungs a t autopsy showed s i g n i f i c a n t l y higher lung v o l . ( a t P5 d e f l a t i o n , 19.3+5.2 vs ll.Gk2.8 ml/kg. PC.02) i n UEgroup. These d a t a suggest UE treatment e s t a b l i s h e s r a p i d a l v e o l a r s t a b il i t y and improves lung compliance f a c i l i t a t i n g rapid drop inMAP. b e t t e r than t h e l a t e t r e a t e d gram. 
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Serum B 1 2 and f o l a t e were measured by RIA in maternal serum, c o r d b l o o d a n d a t 2 wk i n t e r v a l s i n 1 8 LBW i n f a n t s ( g e s t a t i o n a l a g e 29.9 _+ 1.9 weeks, b i r t h w e i g h t 1.18 f .26 kg). A l l i n f a n t s r e c e i v e d p a r e n t e f a l a l i m t a t i o n PA) (18.8 f 13.9 d a y s , r a n g e 2-51 d a s) w l t h s u p p l e m e n t a l B 1 2 ( 5 u g d d a y ) a n d f o l a t e (50 u d d a y ) as recommended b y t h e AAP
P e d i a t r i c N u t r i t i o n Handgook (1979).
A f t e r PA, i n f a n t s r e c e i v e d o n l y B 1 2 and f o l a t e p r e s e n t in f o r n u l a (1.5-2uWl a n d 50-100 u g d l ) . Cord B 1 2 (805 2.8 pg/ml)and f o l a t e (14.6 f 2.8 n /ml) were h i g h e r (p<.01) t h a n m a t e r n a l B 1 2 (464 f 514 %/ml? a n d f o l a t e (4.4 + 4.5 ng/ml). ( A d u l t n o r m a l s :
B 1 2 > 0 pg/mJ., f o l a t e > 4-n /ml). A t two wks B 1 2 a n d f o l a t e were h l g h e r t h a n c o r d l e v e l s (p<.Ol); 88% o f B 1 2 l e v e l s > 2000 /ml and 75% o f f o l a t e l e v e l s > 20 ng/ml. B 1 2 (100% > 2 0 0 0 p g 1 l ) remained > c0rd.B 1 2 (p<0.01) t h r o u h o u t 6 wks PA. F o l a t e (60% >20ng/ml) remain+ > cord f o l a t e qp(0.01) f o r 4 wks PA. B 1 2 a n d f o l a t e o b t a i n e d 6 t o 8 weeks a f t e r d i s c o n t i n u a t i o n o f PA remained h i h e r t h a n c o r d B 1 2 a n d f o l a t e (p<0.01).
Median B 1 2 1530 pg/ml a n d 100% f o l a t e l e v e l s were s t i l l > 20 ng/ml. Changes i n B 1 2 a n d f o l a t e l e v e l s d i d n o t correlate with Hgb, r a t e o f growth, l e n g t h o f PA or l e n g t h o f p o f e e d s . LBW I n f a n t s who r e c e l v e a t least two d a y s o f PA w i t h B 1 2 a n d f o l a t e s u p p l e m e n t a t i o n d o n o t n e e d o r a l s u p p l e m e n t s beyond what is present i n f o r m u l a . W e conclude t h a t t h e p r e s e n t recomrended Intravenous s u p p l e m n t s o f B 1 2 a n d f o l a t e are e x c e s s i v e a n d t h a t l o w e r l e v e l s o f supplementation need t o be assessed. Neonatal Unit, 2nd School of Med., Naples, I t a l y .
Recently s e v e r a l r e p o r t s have suggested some short-term e f f e c t s of moderate hyperbilirubinemia questioning t h e t r e a t m e n t protocols used f o r neonatal jaundice. The majority of t h e s e s t u d i e s were not designed t o t e a s e o u t t h e e f f e c t s bf phototherapy. I n our study with t h e Brazelton ~e b n a t a l Behavioral Scale we evaluated a group of 17 heathy moderately jaundiced term i n f a n t s (mean b i l i r u b i n l e v e l 10.6 mg1100m1, range 8.4-14.3) not t r e a t e d w i t h phototherapy compared t o 1 7 not jaundiced matched s u b j e c t s on t h e 3rd day of l i f e . No d i f f e r e n c e s were found between t h e 2 groups. On t h e 4 t h day of l i f e we evaluated 14 jaundiced s u b j e c t s (mean b i l i r u b i n l e v e l 10.4 mg/lOOml, range 8.4-12.9) and 14 not jaundiced matched i n f a n t s and again we did not f i n d any differences. A t one month of age, 10 ex-jaundiced i n f a n t s (mean b i l i r u b i n l e v e l 11.5mg/lOOml,range 9.1-15.9) and 10 matched not jaundiced s u b j e c t s were a v a i l a b l e , and s t i l l no d i f f e r e n c e s were found between t h e 2 groups. Our d a t a t h e r e f o r e i n d i c a t e t h a t moderate l e v e l s of hyperbilirubinemia do not i n f l u e n c e neonatal behavior. Therefore we do not advocate more aggressive treatment protocols a t l e a s t f o r term i n f a n t s .
